AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 34340163
Drug: Early physical
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early physical therapy (PT) treatment including exercise instructions from the first postoperative day
Trial: 32383985
Drug: Quetiapine augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine augmentation
Trial: 33411115
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment with epoetin beta pegol targeting hemoglobin level of 11 g/dL or higher
Trial: 37316163
Drug: Ticagrelor (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticagrelor (180 mg)
Trial: 35175011
Drug: In-office bleaching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-office bleaching with PNF desensitizing gel (Desensibilize KF 2%) applied for 10 min before each session
Trial: 34088270
Drug: SPI-guided analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SPI-guided analgesia (fentanyl boluses of 1.0 µg/kg to maintain SPI value between 20 and 50)
Trial: 34524022
Drug: Fast-acting insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast-acting insulin aspart (FiAsp)
Trial: 36010630
Drug: PEA‐LUT therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEA‐LUT therapy
Trial: 36315189
Drug: Automated insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Automated insulin dosing (AID)
Trial: 33433644
Drug: 35 mg
RxNorm normalized name: papain 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 mg ASP8062
Trial: 33433644
Drug: 70 mg
RxNorm normalized name: silybin 70 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 mg ASP8062
Trial: 34699549
Drug: Heparin ±
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin ± GPIs
Trial: 39565980
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment alone (control group)
Trial: 34839672
Drug: Immunonutrient-enriched supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunonutrient-enriched supplement for 7 days
Trial: 34839672
Drug: Standard high-protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard high-protein normocaloric supplement (control) for 7 days
Trial: 35496724
Drug: Multimodal chiropractic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal chiropractic treatment including spinal manipulation
Trial: 35496724
Drug: Multimodal chiropractic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal chiropractic treatment including spinal manipulation, together with podiatric custom-made orthoses
Trial: 32087126
Drug: Emollient group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emollient group (Diprobase cream or DoubleBase gel) with standard skin-care advice
Trial: 34547217
Drug: Botulinum neurotoxin
RxNorm normalized name: Botulinum neurotoxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum neurotoxin A therapy (BoNT‐A) with intensive rehabilitation
Trial: 32321717
Drug: Taxane treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taxane treatment (docetaxel)
Trial: 34915104
Drug: Prebiotic (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prebiotic (16 g inulin)
Trial: 34915104
Drug: Control (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (16 g maltodextrin)
Trial: 35783144
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy (10 min of evaluation and warm-up, 40 min of therapist-directed exercise therapy, and 10 min of relaxation, three times per week for 12 weeks)
Trial: 33060506
Drug: Insulin-dependent diabetes
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-dependent diabetes
Trial: 34711060
Drug: Jet injection
RxNorm normalized name: Jet Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jet injection with a slot-shaped nozzle
Trial: 34711060
Drug: Jet injection
RxNorm normalized name: Jet Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jet injection with differently shaped nozzles
Trial: 35833889
Drug: Germinated brown
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Germinated brown rice (GBR), 100 g per day for 12 weeks
Trial: 32648022
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg NZBC extract prior to a high-carbohydrate, high-fat liquid meal (n=12)
Trial: 32648022
Drug: 8-days supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-days supplementation with NZBC extract (600 mg day-1) (n=13)
Trial: 33399381
Drug: Generic preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic preparation of ropivacaine
Trial: 37952132
Drug: Aspirin 81
RxNorm normalized name: aspirin 81 MG
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 81 mg daily
Trial: 34203286
Drug: Combined Creatine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined Creatine and Sodium Bicarbonate (CSB) supplementation (20 g/day creatine and 0.3 g/kg/day sodium bicarbonate, taken four times a day for seven days)
Trial: 33851329
Drug: 10 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/kg Cr(VI)
Trial: 35871058
Drug: EPA-E 2.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA-E 2.7 g/day
Trial: 33298604
Drug: Propofol Target-Controlled
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol Target-Controlled Infusion (TCI)
Trial: 33130104
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g gluten/d for 14 days
Trial: 33130104
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g gluten/d for 14 days
Trial: 35800292
Drug: Denosumab (DB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab (DB group; 120 mg once every 4 weeks with loading doses of 120 mg on days 8 and 15; n = 80)
Trial: 35800292
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid (ZA group; 4 mg once every 4 weeks; n = 80)
Trial: 32993338
Drug: Corticosteroid (CS)
RxNorm normalized name: MyoGesic-CS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid (CS) in periarticular injection
Trial: 32993338
Drug: No corticosteroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No corticosteroid (no-CS) in periarticular injection
Trial: 36192738
Drug: Home stretching
RxNorm normalized name: Mederma Stretch Mark Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home stretching exercises with spinal manipulative therapy
Trial: 34371883
Drug: Metformin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin plus BHC (berberine, hesperidin, and chromium picolinate)
Trial: 34371883
Drug: Metformin only
RxNorm normalized name: Metformin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin only (control group)
Trial: 35027477
Drug: Intrathecal 2-chloroprocaine
RxNorm normalized name: 2-chloroprocaine
DrugBank: Chloroprocaine (DB01161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecal 2-chloroprocaine 1% (27.8 mg estimated ED90 in cohort I, 28 mg fixed dose in cohort II)
Trial: 32678299
Drug: Foot and
RxNorm normalized name: Carrington Foot and Body
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Foot and back massage (6 sessions of 30 min, twice weekly for 3 weeks)
Trial: 35340044
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment with potent topical corticosteroid (TCS) and handheld narrowband ultraviolet B
Trial: 32418143
Drug: Co‐Plavix® (fixed‐dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co‐Plavix® (fixed‐dose combination of 100 mg acetylsalicylic acid and 75 mg clopidogrel)
Trial: 32418143
Drug: Reference formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulations (coadministration of individual formulations of 100 mg acetylsalicylic acid and 75 mg clopidogrel)
Trial: 36174958
Drug: Phase 2
RxNorm normalized name: Premphase 28 Day Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phase 2 trial with randomized evaluation of multiple doses
Trial: 36174958
Drug: Phase 3
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phase 3 trial with selected dose
Trial: 34488824
Drug: Verum acupuncture
RxNorm normalized name: Cinnamomum verum whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verum acupuncture (1-hour sessions, twice a week for 12 weeks)
Trial: 36062831
Drug: EMDR treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMDR treatment (weekly for 3 to 9 months)
Trial: 32753339
Drug: COSMOS intervention
RxNorm normalized name: Cosmos sulphureus flowering top extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COSMOS intervention (Communication, Systematic pain management, Medication reviews, Organization of activities, Safety)
Trial: 38600496
Drug: Control condition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control condition (CC)
Trial: 32889413
Drug: Individualized goal-directed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized goal-directed therapy (GDT)
Trial: 32557506
Drug: 2× PPI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2× PPI (Pantoprazole 40 mg 2×/day)
Trial: 32557506
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (after PPI therapy)
Trial: 36414172
Drug: PRP injection
RxNorm normalized name: Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP injection following arthrocentesis
Trial: 32880220
Drug: Transdermal 17β‐estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17β‐estradiol (50 µg/day) with progesterone (200 mg/day for 12 days/month)
Trial: 32665311
Drug: Buparlisib (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buparlisib (80 mg) plus carboplatin (AUC=5 every 3 weeks)
Trial: 32665311
Drug: Buparlisib (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buparlisib (60 mg) plus lomustine (100 mg/m2 every 6 weeks)
Trial: 32665311
Drug: Buparlisib (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buparlisib (80 mg or 100 mg) plus carboplatin or buparlisib (60 mg) plus lomustine
Trial: 35636766
Drug: No preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No preparation (NMBP)
Trial: 32248638
Drug: Biobehavioral intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Biobehavioral intervention (12 weekly, 30-minute telehealth sessions)
Trial: 33642330
Drug: DEX (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DEX (intravenous injection; 0.5 μg/kg)
Trial: 33642330
Drug: LID (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LID (1.5 mg/kg)
Trial: 33642330
Drug: PBO (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PBO (10 mL normal saline)
Trial: 35794623
Drug: Nintedanib 150
RxNorm normalized name: nintedanib 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nintedanib 150 mg bid
Trial: 34077602
Drug: Combined self‐management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined self‐management and exercise programme (treatment group)
Trial: 35690997
Drug: Control vehicle
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control vehicle lotion
Trial: 32073177
Drug: MDMA (75-125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDMA (75-125 mg)
Trial: 34083744
Drug: Extended-release naltrexone/bupropion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release naltrexone/bupropion (NB)
Trial: 34259193
Drug: Sequential therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential therapy (SQT): esomeprazole 20 mg twice daily for 10 days, amoxicillin 1000 mg twice daily for 5 days, clarithromycin 500 mg and tinidazole 500 mg twice daily for 5 days
Trial: 33115428
Drug: Pharmacogenetic testing
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacogenetic testing (PGx) for antidepressant prescribing
Trial: 35045208
Drug: LC51‐0255 (0.25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LC51‐0255 (0.25, 0.5, 1, 2, or 4 mg)
Trial: 35172273
Drug: StemPrintER Risk
RxNorm normalized name: Hep B, adolescent/high risk infant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: StemPrintER Risk Score (SPRS) with Clinical Treatment Score (CTS)
Trial: 35172273
Drug: Oncotype DX
RxNorm normalized name: brompheniramine maleate / dextromethorphan hydrobromide / pseudoephedrine hydrochloride Oral Solution [Myphetane DX]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oncotype DX Recurrence Score (RS) with Clinical Treatment Score (CTS)
Trial: 35172273
Drug: StemPrintER Risk
RxNorm normalized name: Hep B, adolescent/high risk infant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: StemPrintER Risk Score (SPRS) in node-negative patients with Clinical Treatment Score (CTS)
Trial: 35373443
Drug: Low-Dose-Rate Brachytherapy
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Dose-Rate Brachytherapy (BT)
Trial: 33865239
Drug: Intermediate-dose prophylactic
RxNorm normalized name: Prevotella intermedia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermediate-dose prophylactic anticoagulation
Trial: 32992075
Drug: Matching placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matching placebo for atorvastatin
Trial: 33865239
Drug: Standard-dose prophylactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose prophylactic anticoagulation
Trial: 35585641
Drug: Standard schizonticidal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard schizonticidal treatment plus 7-day high dose primaquine (total dose 7mg/kg)
Trial: 36436076
Drug: Costoclavicular brachial
RxNorm normalized name: Brachiara mutica pollen
DrugBank: Urochloa mutica pollen (DB10716)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Costoclavicular brachial plexus block (CC group)
Trial: 35405965
Drug: Green mandarin
RxNorm normalized name: mandarin oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green mandarin extract (PTE) 300 mg/day for 12 weeks
Trial: 34229149
Drug: ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: ibuprofen
Trial: 34034400
Drug: Prophylactic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic treatment with suplatast tosilate.
Trial: 33114364
Drug: WS group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WS group 1 (500 mL purified water)
Trial: 33114364
Drug: WS group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WS group 2 (200 mL purified water)
Trial: 33114364
Drug: WS group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WS group 3 (100 mL purified water)
Trial: 32078484
Drug: LDL cholesterol
RxNorm normalized name: LDL cholesterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDL cholesterol <70 mg/dL
Trial: 32078484
Drug: LDL cholesterol
RxNorm normalized name: LDL cholesterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDL cholesterol 100±10 mg/dL (90-110 mg/dL)
Trial: 32933153
Drug: Krill Oil
RxNorm normalized name: Krill oil
DrugBank: Krill oil (DB16615)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Krill Oil (KO) 1.27 g/day of long-chain omega-3 PUFA (0.76 g EPA, 0.42 g DHA)
Trial: 32933153
Drug: Fish Oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish Oil (FO) 1.44 g/day of long-chain omega-3 PUFA (0.79 g EPA, 0.47 g DHA)
Trial: 35932394
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard smoking cessation treatment)
Trial: 37482564
Drug: Abrocitinib 100
RxNorm normalized name: abrocitinib 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abrocitinib 100 mg once daily
Trial: 34897593
Drug: Zhuang medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zhuang medicine medicated thread moxibustion (ZMTM) combined with Western medicines
Trial: 34897593
Drug: Western medicines
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicines alone (pidotimod dispersible tablets, vitamin B compound tablets, compound cod liver oil‐zinc oxide ointment)
Trial: 34897593
Drug: ZMTM combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZMTM combined with Western medicines
Trial: 34967864
Drug: tSVF injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tSVF injection in the lateral 5 cm of the horizontal scar of 1 breast
Trial: 34967864
Drug: Placebo injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo injection in the contralateral breast
Trial: 35591203
Drug: Balance and
RxNorm normalized name: ZINC OXIDE 132 mg in 1 mL TOPICAL LOTION [Sunsolve MD Balance and Clear]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balance and coordination training with vibrotactile sensory augmentation (SA)
Trial: 35591203
Drug: Balance and
RxNorm normalized name: ZINC OXIDE 132 mg in 1 mL TOPICAL LOTION [Sunsolve MD Balance and Clear]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balance and coordination training without vibrotactile sensory augmentation (SA)
Trial: 34493431
Drug: TAS-115 600
RxNorm normalized name: Ta
DrugBank: Tantalum (DB12859)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAS-115 600 mg/d
Trial: 34493431
Drug: TAS-115 400
RxNorm normalized name: Ta
DrugBank: Tantalum (DB12859)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAS-115 400 mg/d
Trial: 36394838
Drug: DCVax-L plus
RxNorm normalized name: DCVax-L
DrugBank: DCVax-L (DB17580)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DCVax-L plus SOC temozolomide
Trial: 33965626
Drug: Double dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double dose of antenatal corticosteroids (ACS)
Trial: 33965626
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of antenatal corticosteroids (ACS)
Trial: 36215414
Drug: Alfentanil 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 20 μg/kg ideal bodyweight
Trial: 33350678
Drug: Second-line therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-line therapy (37% of patients received this treatment)
Trial: 33350678
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no second-line therapy)
Trial: 37035316
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical treatment (SMT)
Trial: 33810451
Drug: >Your< Iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: >Your< Iron Syrup
Trial: 35411147
Drug: Intravenous glutamine
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous glutamine (0.5 g/kg of 20% glutamine solution diluted with 0.9% NaCl up to 500 mL over 24 hours)
Trial: 34406354
Drug: Escitalopram (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram (up to 20 mg per day for 12 weeks)
Trial: 36088373
Drug: Crisis-focused Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crisis-focused Cognitive Behavioural Therapy for psychosis (CBTp)
Trial: 34389701
Drug: D-fortified yogurt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-fortified yogurt drink (DY; containing 1000 IU vitamin D and 300 mg calcium)
Trial: 34086518
Drug: Concurrent training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent training (CON, N=13)
Trial: 35796290
Drug: Lactuca Sativa
RxNorm normalized name: Lactuca sativa l.
DrugBank: Lactuca sativa whole (DB15604)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactuca Sativa syrup (3 times a day for 72 hours)
Trial: 33094958
Drug: Tailored therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailored therapy
Trial: 34910367
Drug: 1% VC-IP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% VC-IP cream
Trial: 34701458
Drug: GC4711 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GC4711 100 mg IV infusion prior to each SBRT (5×10Gy)
Trial: 34701458
Drug: Placebo IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo IV infusion prior to each SBRT (5×10Gy)
Trial: 34528277
Drug: IV administration
RxNorm normalized name: IV Administration Set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV administration of dexmedetomidine (loading dose 1.75 mcg/kg bwt followed by 1.75 mcg/kg bwt/h) with concurrent target sevoflurane dose reduction of 50%.
Trial: 34528277
Drug: No further
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No further treatment (group LPS; seven horses).